Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Diana V. Maslov"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Prostate cancer is the most common cancer in men. About 6% of those diagnosed will develop metastatic disease. Unfortunately, metastatic prostate cancer is fatal. Prostate cancer can be castration sensitive or castration resistant. Many treatments ha
Externí odkaz:
https://doaj.org/article/780d16ecaf164dd084f8084ad4340331
Autor:
Diana V. Maslov, Ambuga Badari
Publikováno v:
Case Reports in Oncological Medicine, Vol 2021 (2021)
Acute lymphoblastic leukemia (ALL) is a neoplasm of the B cell or T cell. Diagnosis is made by peripheral blood smear and bone marrow biopsy. Those with relapse/measurable residual disease (MRD) present with fever, weakness, fatigue, and easy bruisin
Externí odkaz:
https://doaj.org/article/1a181cc0e4fa488499be19c3759494d8
Publikováno v:
TH Open, Vol 04, Iss 03, Pp e175-e177 (2020)
Novel coronavirus disease 2019 (COVID-19) has spread throughout the world and has infected close to 4 million people. It commonly presents with fever, cough, and fatigue. Due to the high inflammatory response, it is suggested that the coagulation cas
Externí odkaz:
https://doaj.org/article/386d829ec47849289622a1e7d1df3af3
Autor:
Ambuga Badari, Diana V. Maslov
Publikováno v:
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine, Vol 2021 (2021)
Case Reports in Oncological Medicine, Vol 2021 (2021)
Acute lymphoblastic leukemia (ALL) is a neoplasm of the B cell or T cell. Diagnosis is made by peripheral blood smear and bone marrow biopsy. Those with relapse/measurable residual disease (MRD) present with fever, weakness, fatigue, and easy bruisin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec6922ddc77f34c8852ed1e8d42f59e
http://europepmc.org/articles/PMC8639275
http://europepmc.org/articles/PMC8639275
Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer
Autor:
Richa Goel, Zoe Blake, Daniel H Johnson, Karine Tawagi, Victoria Simenson, Helen Yuan, Cameron Parent, Adi Bamnolker, Diana V Maslov, Madhav KC, Marc R Matrana
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Corticosteroids (CS) are the mainstay of immune-related adverse effect (irAE) management, as well as for other indications in cancer treatment. Previous studies evaluating whether CS affect immune checkpoint inhibitor (CPI) efficacy compar
Externí odkaz:
https://doaj.org/article/7e05a514ecb848528e1b3ad38629794a